Maternal Lipid Dynamics and Pregnancy Outcomes

Pregnancy induces profound shifts in maternal lipid metabolism to support foetal growth and prepare maternal tissues for parturition and lactation. Early gestation is often marked by modest declines in total cholesterol and triglycerides, followed by steep rises in the second and third trimesters driven by hormonal regulation of hepatic lipid synthesis and altered lipoprotein clearance. These changes facilitate placental lipid transfer, ensuring adequate substrate supply for foetal organogenesis and energy storage. However, exaggerated dyslipidaemia—characterised by elevated triglycerides, cholesterol fractions or apolipoproteins—has been implicated in a spectrum of adverse outcomes, including preeclampsia, gestational diabetes mellitus and preterm birth. Lipoprotein oxidation and endothelial dysfunction appear to underlie defective placentation and vascular maladaptation, while persistent maternal dyslipidaemia may programme long-term cardiometabolic risk in both mother and offspring. Understanding the fine balance between physiological adaptation and pathological lipid profiles is essential for identifying at-risk pregnancies and developing targeted interventions.

Research from Nature Portfolio

Recent analyses of a large hospital cohort have revealed that aberrant lipid profiles in early pregnancy are independently associated with heightened risk of preterm birth. Women who delivered prematurely exhibited higher quartile levels of apolipoprotein A, apolipoprotein B, total cholesterol, low-density lipoprotein and triglycerides in the first trimester. Statistical modelling demonstrated that, after adjustment for maternal age, body mass index and comorbidities, the highest lipid quartiles conferred up to a twofold increase in preterm birth risk. These findings suggest that early screening and management of dyslipidaemia may offer a window to mitigate preterm delivery and its long-term sequelae.

Maternal Lipid Dynamics and Pregnancy Outcomes publication trend

The graph below shows the total number of articles in maternal lipid dynamics and pregnancy outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Triglycerides: The main form of stored fat in the body, elevated levels of which can signal impaired lipid metabolism.

High-density lipoprotein (HDL): A class of lipoprotein particles that transport cholesterol from peripheral tissues to the liver for excretion.

Low-density lipoprotein (LDL): A class of lipoprotein particles that deliver cholesterol to tissues, high levels of which are associated with atherogenesis.

Apolipoprotein: Protein components of lipoprotein particles that regulate lipid binding, transport and receptor interactions.

Dyslipidaemia: An abnormal lipid profile, typically involving elevated triglycerides or cholesterol fractions, linked to cardiovascular risk.

Preeclampsia: A hypertensive disorder of pregnancy characterised by new-onset hypertension and end-organ dysfunction after 20 weeks’ gestation.

Gestational diabetes mellitus (GDM): Glucose intolerance first recognised during pregnancy, associated with maternal and foetal complications.

Preterm birth: Delivery before 37 completed weeks of gestation, a leading cause of neonatal morbidity and mortality.

Metabolic syndrome: A cluster of risk factors—including central obesity, dyslipidaemia, hypertension and hyperglycaemia—that predispose to cardiovascular disease.

References

1. Preeclampsia Affects Lipid Metabolism and HDL Function in Mothers and Their Offspring. Antioxidants (2023).
2. The association between pregnancy levels of blood lipids and the risk of preterm birth. Scientific Reports (2024).
3. Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women. PLOS Medicine (2018).